18F-fluorodeoxyglucose (FDG) positron emission tomography-computed-tomography (PET CT) as part of radical radiotherapy treatment planning for oesophageal cancer (all ages)

NHS England | April 2019 | 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed-tomography (PET CT) as part of radical radiotherapy treatment planning for oesophageal cancer (all ages)

NHS England will not routinely commission 18F-FDG-PET CT as part of radical radiotherapy treatment planning for oesophageal cancer in accordance with the criteria outlined in this document.

In creating this policy NHS England has reviewed this clinical condition and the options for its treatment. It has considered the place of this treatment in current clinical practice, whether scientific research has shown the treatment to be of benefit to patients, (including how any benefit is balanced against possible risks) and whether its use represents the best use of NHS resources (Source: NHS England).

Further details including the evidence review, evidence report and clinical panel report are available from NHS England.

Pazopanib for inoperable and metastatic malignant granular cell tumour (all ages)

NHS England | April 2019 | Pazopanib for inoperable and metastatic malignant granular cell tumour (all ages)

NHS England have released a  policystatement to confirm that pazopanib is not recommended as a treatment option for inoperable and metastatic malignant granular cell tumours (all ages).

Policy Statement: Pazopanib for inoperable and metastatic malignant granular cell tumour

Pazopanib for inoperable and metastatic malignant granular cell tumour: Engagement Report

Pazopanib for inoperable and metastatic malignant granular cell tumour: CPAG Summary Report

Pazopanib for inoperable and metastatic malignant granular cell tumour: Clinical Panel Report

Waiting times for suspected and diagnosed cancer patients for February 2019

NHS England | | April 2019 | Waiting times for suspected and diagnosed cancer patients for February 2019

These reports present the validated results of the monitoring of waiting times for cancer services in England and the information on the number of people who attended outpatient appointments within two weeks of an urgent referral by their GP for suspected cancer or breast symptoms and, for patients with cancer, on the numbers who started treatment within 31 and 62 days are included for each organisation. The numbers who started some types of subsequent treatments within 31 days are also given for each organisation. Numbers of patients who were not seen or treated within the specified times are also included (Source: NHS England).

room-44085_640.png

Waiting times for suspected and diagnosed cancer patients for February 2019

Improving patient experience through stratification of the prostate cancer follow up pathway

Atlas of Shared Learning | March 2019| Improving patient experience through stratification of the prostate cancer follow up pathway

A recent addition to NHS England’s Atlas of Shared Learning is a case study that comes from nurses in the Urology Unit at The Royal Marsden NHS Foundation Trust who led the development and implementation of a new prostate cancer follow-up pathway. This pathway has significantly improved patient outcomes, experience and use of resources locally (Source: NHS England).

Read the case study at NHS England 

Targeted Screening for Lung Cancer with Low Radiation Dose Computed Tomography

NHS England | February 2019 | Targeted Screening for Lung Cancer with Low Radiation Dose Computed Tomography Standard Protocol prepared for the Targeted
Lung Health Checks Programme

This document outlines the service and quality indicators expected by NHS England to ensure that a high standard of service is provided for targeted screening for lung cancer across England.

Targeted Screening for Lung Cancer with Low Radiation Dose Computed Tomography

Introducing group consultations for cancer care reviews

NHS England | January 2019 | Introducing group consultations for cancer care reviews

A new case study has been published on NHS England’s Shared Atlas of Learning; it underlines the impact of a general practice nurse (GPN) at Lancaster Medical Practice idea to address unwarranted variation relating to cancer care reviews by introducing a group consultation model at the surgery. 

Following completion of an accredited education programme on group consultations, the practice nurse established a gynaecological cancer group consultation at the surgery as a trial. Patients with similar cancers who were living with and beyond cancer were invited to attend.

pexels-photo-942418.jpeg

Due to the success of the initial trial, a further group consultation session was arranged to roll-out the offer of support, review progress and identify new needs as well as ensuring previous concerns had been addressed.

The new approach has led to consistency in cancer care reviews and information given to patients about cancer and the impact on their health. 25% capacity saving has been achieved and time spent consulting has had greater impact and service improvements can be seen now that all information and peer support is provided.

Challenges and lessons learnt for implementation

It can be challenging when working with a large team from different backgrounds but it is worth it.

There is reinforced learning in recognising the need to improve practice and lead on change for the benefit of patients and communities even when this change is outside of your comfort zone.

Speaking with stakeholders will support successful improvements to be implemented on a broader scale to reduce unwarranted variation.

Due to the success of the programme, the practice nurse and practice manager won the ‘Most Innovative Group Consultation’ award from Health Education England (HEE) at the North-West Group Consultation Celebration Event in October 2017, and in November 2017 won the ‘Supporting Families and Carers’ award at the NHS England Regional General Practice Nursing Conference (Source: NHS England).

Read the full,unabridged case study at NHS England  

NHS70: spotlight on cancer

NHS England |August 2018 |NHS70: spotlight on cancer

More people are surviving cancer than ever before. As we continue to celebrate 70 years of the NHS, we shine the spotlight on some of the key milestones that improved cancer diagnosis, treatment and care over the decades, as well as looking to the future on NHS cancer care.

NHS England will also explore some of the work of the National Cancer Programme, as the NHS implements an ambitious. They have produced a timeline of cancer care improvements in cancer prevention, treatment and care (Source: NHS England).

You can watch the video here:

 

The NHS has played a major role in advancing cancer treatment and care locally, nationally and globally. In this video, we acknowledge some of the key milestones that marked huge improvements in cancer prevention, treatment and care.

 

Full details are available from NHS England